Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deal Watch: Merck Hopes Moderna's Personalized Vaccines Can Increase Keytruda Patient Base

Executive Summary

Novartis and Xencor sign wide-ranging immuno-oncology collaboration targeting multiple CD pathways. Teva signs divestment agreements with five firms during June to meet FTC requirements for its acquisition of Allergan's generics business.


Related Content

Deal Watch: Bristol Leaves Neuropathic Pain Candidate To Lexicon
Regeneron’s Fasinumab Brings Second Clinical Hold For Anti-NGF Class
Sanofi Looks To Climb Consumer Ladder In Boehringer Business Swap
Infinity Gets More Than A Cash Boost With AbbVie Tie-Up


Related Companies

Related Deals